Invitrogen™ Human TMEM106B Synthetic Peptide

Ref.: BL-RE-175646Manufacturer ref.: PEP-1396 50 μg
€149.00 excl. VAT

TMEM106B Synthetic Peptide, PEP-1396, from Invitrogen.

Gene ID (Enter)
54664
Species
Human
Purification method
Purified
Accession number
Q9NUM4
Common name
Human TMEM106B
Brand
Invitrogen

TMEM106B Synthetic Peptide, PEP-1396, from Invitrogen.

TMEM106B Synthetic Peptide, PEP-1396, from Invitrogen.

Transmembrane protein 106B (TMEM106B) is a single-pass transmembrane protein that is thought to be a novel risk factor for frontotemporal lobar degeneration (FTLD), a group of clinically, pathologically and genetically heterogeneous disorders associated with atrophy in the frontal lobe and temporal lobe of the brain. The actual role of TMEM106B, and that of the closely related protein TMEM106A are still undetermined.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15215309
Specifications
Gene ID (Enter)54664
SpeciesHuman
Purification methodPurified
Accession numberQ9NUM4
Common nameHuman TMEM106B
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)TMEM106B
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-1396
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.